Curt Dewan
Chief Financial Officer
Professional Overview
Curt Dewan is an accomplished financial executive with over 15 years of experience in the pharmaceutical and biopharmaceutical industries. As the Chief Financial Officer at Walden Biosciences, he oversees all financial operations, strategic planning, and business development initiatives, driving the company's financial growth and operational efficiency.
Experience Summary
Current Role
As the Chief Financial Officer at Walden Biosciences, Curt is responsible for managing the company's financial operations, including budgeting, forecasting, and reporting. He plays a pivotal role in shaping the organization's strategic direction, collaborating with the executive team to identify growth opportunities and implement financial strategies that support the company's long-term objectives. Curt's strategic leadership and financial expertise have been instrumental in securing funding and driving the company's expansion within the biopharmaceutical sector.
Career Progression
Prior to his current role, Curt served as the Vice President and Head of Finance at Walden Biosciences, where he oversaw the company's financial planning, analysis, and reporting functions. He also held various finance and business development positions at Servier Pharmaceuticals and Shire, where he demonstrated his ability to optimize financial operations, drive cost savings, and support the company's growth initiatives. Curt's diverse background and progressive career trajectory have equipped him with a comprehensive understanding of the pharmaceutical industry and the financial levers that drive organizational success.
Academic Background
Curt holds a Bachelor of Commerce degree in Accounting and Finance from the University of Toronto, where he graduated with distinction. He is a Certified Public Accountant (CPA) and has completed executive management programs at Harvard Business School, further enhancing his financial expertise and strategic leadership capabilities.
Areas of Expertise
- Financial planning and analysis
- Budgeting and forecasting
- Mergers and acquisitions
- Investor relations and fundraising
- Business strategy and operational optimization
- Cross-functional collaboration and team leadership
Professional Impact
Throughout his career, Curt has consistently delivered measurable financial and operational improvements for the organizations he has served. At Walden Biosciences, he has played a pivotal role in securing $50 million in Series B funding, enabling the company to accelerate its research and development initiatives. Curt's strategic guidance and innovative financial solutions have contributed to the company's successful expansion into new therapeutic areas, further solidifying its position as a leader in the biopharmaceutical industry.
Conclusion
With his extensive financial expertise, strategic mindset, and deep industry knowledge, Curt Dewan is a valuable asset to Walden Biosciences. As the Chief Financial Officer, he continues to drive the company's financial growth, optimize its operations, and contribute to its long-term success within the competitive biopharmaceutical landscape.
